Measles virus vaccine live attenuated

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Measles virus vaccine live attenuated
Accession Number
DB10315
Description

Measles virus vaccine live attenuated is a live virus vaccine for simultaneous vaccination against measles, which is a common childhood disease. The vaccine is prepared from the attenuated line of measles virus, derived from Enders' attenuated Edmonston strain and propagated in chick embryo cell culture.

Type
Biotech
Groups
Approved, Investigational
Biologic Classification
Vaccines
Attenuated
Synonyms
  • Live attenuated measles virus (Schwartz strain)
  • Measles vaccine (live)
  • Measles virus live antigen
  • Measles virus live antigen, A
  • Measles virus strain enders' attenuated edmonston live (attenuated) antigen
  • Measles virus strain enders' attenuated edmonston live antigen
  • Measles virus vaccine live
  • Measles virus vaccine live attenuated
  • Measles Virus Vaccine Live, Enders' attenuated Edmonston strain
  • Measles virus vaccine, inactivated
  • Measles virus vaccine, live
  • Measles virus vaccine, live, attenuated
  • Measles virus vaccine,live attenuated

Pharmacology

Pharmacology
Accelerate your drug discovery research with the industry’s only fully connected ADMET dataset, ideal for:
Machine Learning
Data Science
Drug Discovery
Accelerate your drug discovery research with our fully connected ADMET dataset
Learn more
Indication
Not Available
Associated Conditions
Contraindications & Blackbox Warnings
Contraindications
Contraindications & Blackbox Warnings
With our commercial data, access important information on dangerous risks, contraindications, and adverse effects.
Learn more
Our Blackbox Warnings cover Risks, Contraindications, and Adverse Effects
Learn more
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Medicalerrors
Reduce medical errors
and improve treatment outcomes with our comprehensive & structured data on drug adverse effects.
Learn more
Reduce medical errors & improve treatment outcomes with our adverse effects data
Learn more
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AbataceptThe therapeutic efficacy of Measles virus vaccine live attenuated can be decreased when used in combination with Abatacept.
AdalimumabThe therapeutic efficacy of Measles virus vaccine live attenuated can be decreased when used in combination with Adalimumab.
AldesleukinThe therapeutic efficacy of Measles virus vaccine live attenuated can be decreased when used in combination with Aldesleukin.
AlefaceptThe therapeutic efficacy of Measles virus vaccine live attenuated can be decreased when used in combination with Alefacept.
AlemtuzumabThe therapeutic efficacy of Measles virus vaccine live attenuated can be decreased when used in combination with Alemtuzumab.
AltretamineThe therapeutic efficacy of Measles virus vaccine live attenuated can be decreased when used in combination with Altretamine.
AmsacrineThe therapeutic efficacy of Measles virus vaccine live attenuated can be decreased when used in combination with Amsacrine.
AnakinraThe therapeutic efficacy of Measles virus vaccine live attenuated can be decreased when used in combination with Anakinra.
Antilymphocyte immunoglobulin (horse)The therapeutic efficacy of Measles virus vaccine live attenuated can be decreased when used in combination with Antilymphocyte immunoglobulin (horse).
Antithymocyte immunoglobulin (rabbit)The therapeutic efficacy of Measles virus vaccine live attenuated can be decreased when used in combination with Antithymocyte immunoglobulin (rabbit).
Interactions
Improve patient outcomes
Build effective decision support tools with the industry’s most comprehensive drug-drug interaction checker.
Learn more
Food Interactions
Not Available

Products

Products
Comprehensive & structured drug product info
From application numbers to product codes, connect different identifiers through our commercial datasets.
Learn more
Easily connect various identifiers back to our datasets
Learn more
Brand Name Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Measles Virus Vacc Live Att Freez Dried InjPowder, for solutionSubcutaneousIaf Biovac Inc.1991-12-311997-08-20Canada flag
Measles Virus Vaccine Live Atten DriedPowder, for solutionSubcutaneousConnaught Laboratories Ltd.1982-12-312000-07-18Canada flag
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
M-M-R IIMeasles virus vaccine live attenuated (1000 [TCID_50]/0.5mL) + Mumps virus strain B level jeryl lynn live antigen (12500 [TCID_50]/0.5mL) + Rubella virus vaccine (1000 [TCID_50]/0.5mL)Injection, powder, lyophilized, for suspensionSubcutaneousMerck Sharp & Dohme Corp.1971-04-21Not applicableUS flag
M-M-R IIMeasles virus vaccine live attenuated (1000 TCID50/0.5mL) + Mumps virus strain B level jeryl lynn live antigen (12500 TCID50/0.5mL) + Rubella virus vaccine (1000 TCID50/0.5mL)Powder, for solutionSubcutaneousMerck Ltd.1979-12-31Not applicableCanada flag
M-M-R IIMeasles virus vaccine live attenuated (1000 [TCID_50]/0.5mL) + Mumps virus strain B level jeryl lynn live antigen (12500 [TCID_50]/0.5mL) + Rubella virus vaccine (1000 [TCID_50]/0.5mL)Injection, powder, lyophilized, for suspensionSubcutaneousA-S Medication Solutions1971-04-21Not applicableUS flag
M-M-R IIMeasles virus vaccine live attenuated (1000 [TCID_50]/0.5mL) + Mumps virus strain B level jeryl lynn live antigen (12500 [TCID_50]/0.5mL) + Rubella virus vaccine (1000 [TCID_50]/0.5mL)Injection, powder, lyophilized, for suspensionSubcutaneousPhysicians Total Care, Inc.1996-08-072012-06-30US flag
M-M-rvaxproMeasles virus vaccine live attenuated (1000 TCID50) + Mumps virus strain B level jeryl lynn live antigen (12500 TCID50) + Rubella virus vaccine (1000 TCID50)Msd Vaccins2021-02-10Not applicableEU flag
M-M-rvaxproMeasles virus vaccine live attenuated (1000 TCID50) + Mumps virus strain B level jeryl lynn live antigen (12500 TCID50) + Rubella virus vaccine (1000 TCID50)Injection, powder, for suspensionIntramuscular; SubcutaneousMsd Vaccins2021-02-10Not applicableEU flag
M-M-rvaxproMeasles virus vaccine live attenuated (1000 TCID50) + Mumps virus strain B level jeryl lynn live antigen (12500 TCID50) + Rubella virus vaccine (1000 TCID50)Msd Vaccins2021-02-10Not applicableEU flag
M-M-rvaxproMeasles virus vaccine live attenuated (1000 TCID50) + Mumps virus strain B level jeryl lynn live antigen (12500 TCID50) + Rubella virus vaccine (1000 TCID50)Msd Vaccins2021-02-10Not applicableEU flag
M-M-rvaxproMeasles virus vaccine live attenuated (1000 TCID50) + Mumps virus strain B level jeryl lynn live antigen (12500 TCID50) + Rubella virus vaccine (1000 TCID50)Msd Vaccins2021-02-10Not applicableEU flag
M-M-rvaxproMeasles virus vaccine live attenuated (1000 TCID50) + Mumps virus strain B level jeryl lynn live antigen (12500 TCID50) + Rubella virus vaccine (1000 TCID50)Injection, powder, for suspensionIntramuscular; SubcutaneousMsd Vaccins2021-02-10Not applicableEU flag

Categories

Drug Categories
Classification
Not classified

Chemical Identifiers

UNII
MFZ8I7277D
CAS number
Not Available

References

General References
Not Available
PubChem Substance
347910494
RxNav
804179
AHFS Codes
  • 80:12.00 — Vaccines

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4CompletedPreventionBCG Infection / Immune Response / Reaction - Vaccine1
4CompletedPreventionChickenpox / Hepatitis A / Mumps / Rubella / Rubeola1
4CompletedPreventionEncephalitis, Japanese B / Mumps / Rubella / Rubeola1
4CompletedPreventionHepatitis A Virus1
4CompletedPreventionMumps / Rubella / Rubeola2
3CompletedPreventionAcellular Pertussis / Diphtheria / Poliomyelitis / Tetanus1
3CompletedPreventionAcellular Pertussis / Diphtheria / Tetanus1
3CompletedPreventionBacterial Infections / Neisseria Meningitidis / Virus Diseases2
3CompletedPreventionBacterial Infections / Virus Diseases1
3CompletedPreventionChickenpox Vaccines / Varicella1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Injection, powder, lyophilized, for solutionSubcutaneous
Injection, powder, lyophilized, for suspensionSubcutaneous
Injection, powder, for suspensionIntramuscular; Subcutaneous
Injection, powder, lyophilized, for solutionSubcutaneous
Injection, powder, for solution
Powder, for solutionSubcutaneous
Kit; liquid; powder, for solutionSubcutaneous
Injection, powder, lyophilized, for solutionIntramuscular; Subcutaneous
Injection, powder, for solutionSubcutaneous
Kit; powder, for solutionIntramuscular; Subcutaneous
Injection, solutionIntramuscular; Subcutaneous
Injection, powder, for solutionIntramuscular; Subcutaneous
Injection
Injection, powder, lyophilized, for suspensionIntramuscular; Subcutaneous
Powder, for solutionSubcutaneous
Injection, powder, lyophilized, for suspensionSubcutaneous
Solution
Injection, suspension
InjectionSubcutaneous
Injection, powder, lyophilized, for suspension
Powder
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created on December 01, 2015 20:03 / Updated on April 11, 2021 00:58